NCT06577493View on ClinicalTrials.gov

Effectiveness of Phenazopyridine for Pain Following Urodynamics

PHASE4RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Pain After Urodynamic Testing
Interventions
DRUG

Phenazopyridine Hydrochloride 99.5 MG

Experimental arm to take two 99.5 mg phenazopyridine hydrochloride by mouth for a total of 199mg immediately prior to start of urodynamic testing

Trial Locations (1)

33606

RECRUITING

University of South Florida South Tampa Center, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER